Organization (Industry)
DANAHER CORPORATION
ClinicalTrials.gov lists DANAHER CORPORATION as lead sponsor of 19 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
16 sections measured, none recorded
Logo KarimKoueider, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers DANAHER CORPORATION and 2 companies grouped under it: 19 lead-sponsored trials (0 its own, 19 in the grouped companies) and 18 legal-entity registrations (16 its own, 2 in the grouped companies).
Companies grouped under this page (2)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| RADIOMETER MEDICAL ApS | 19 | 1 |
| BECKMAN COULTER INDIA PRIVATE LIMITED | 0 | 1 |
Disease areas (11)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Heart Failure | 2 |
| Ankle Fractures | 1 |
| Ankle Injuries | 1 |
| Congenital Hyperinsulinism | 1 |
| Fractures, Bone | 1 |
Showing 5 of 11 disease areas.
Trials by start year as sponsor or collaborator (1)
| Year | Trials started |
|---|---|
| 2024 | 1 |
No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
Journals published in (1)
| Journal | Publications |
|---|---|
| Scandinavian journal of clinical and laboratory investigation | 1 |
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 74 | 29 | 2025-12-16 |
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Congenital Hyperinsulinism International | Co sponsors trial with | 1 |
| Aarhus University Hospital Skejby | Co sponsors trial with | 1 |
Latest dated events (100)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-16 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-11-25 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 100 events.
Biomarker capability evidence (4)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ERBB2 | Trial collaborator | Named in trial inclusion criteria |
| ESR1 | Trial collaborator | Named in trial inclusion criteria |
| ERBB2 | Trial collaborator | Mentioned in trial text |
| ESR1 | Trial collaborator | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.